Docci D, Bilancioni R, Buscaroli A, Baldrati L, Capponcini C, Mengozzi S, Turci F, Feletti C
Servizio di Nefrologia e Dialisi e, Ospedale M. Bufalini, Cesena, Italy.
Nephron. 1990;56(4):364-7. doi: 10.1159/000186176.
Serum C-reactive protein (CRP) levels were measured by nephelometry in 30 healthy subjects (controls) and in 99 patients with uncomplicated terminal uremia on conservative therapy (group 1, n = 30) or chronic hemodialysis (group 2, n = 69). Whereas there was no difference between controls and group 1, both the mean concentration of CRP and the incidence of elevated levels were significantly higher in group 2 in comparison with both controls and group 1. Moreover, the degree of increase in these patients was directly correlated with the duration of hemodialysis. The abnormality, therefore, is somehow related to chronic hemodialysis per se. From a practical standpoint, we concluded that this test cannot be recommended as an acute-phase reactant in this clinical setting.
通过比浊法测定了30名健康受试者(对照组)以及99名接受保守治疗的非复杂性终末期尿毒症患者(第1组,n = 30)或慢性血液透析患者(第2组,n = 69)的血清C反应蛋白(CRP)水平。对照组和第1组之间无差异,但与对照组和第1组相比,第2组的CRP平均浓度和升高水平的发生率均显著更高。此外,这些患者的升高程度与血液透析时间直接相关。因此,这种异常在某种程度上与慢性血液透析本身有关。从实际角度来看,我们得出结论,在这种临床情况下,不能推荐将该检测作为急性期反应物。